Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
DNLI - TOTAL CURRENT ASSETS
Total Current Assets DNLI - Denali Therapeutics Inc.
1.06 B
LAST VALUE
8.90%
2 YEAR CAGR
17.22%
5 YEAR CAGR
0.00%
10 YEAR CAGR